George Scangos Insider Profile

4 Followers
George Scangos, CEO, Director at Biogen, holds 2.08M shares in Vir Biotechnology (Ticker: VIR), holds 36.47K shares in Agilent (Ticker: A), holds 738.31K shares in Exelixis (Ticker: EXEL).
tipranks
George Scangos

George Scangos
Biogen (BIIB)
CEO, Director

Ranked #17,722 out of 99,218 Corporate Insiders

Profitable Transactions

71%
5 out of 7 Profitable Transactions

Average Return

+11.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$64M
41.66%
31.15%
19.44%
7.76%
0.00% Others
A breakdown of George Scangos's holdings

Insider Roles

Exelixis
(EXEL)
Director
Vir Biotechnology
(VIR)
Director
Biogen
(BIIB)
CEO, Director
Agilent
(A)
Director
+1 other positions
Roles that George Scangos holds in companies

Most Profitable Insider Trade

Stock:
Vir Biotechnology
(VIR)
Rating:Informative Sell
Date:Feb 21, 2023 - Feb 21, 2024
Return:+62.50%
The most profitable trade made by George Scangos

George Scangos's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biogen
Jul 22, 2016
CEO, Director
Uninformative Sell
43.96K
$12.49M
Vir Biotechnology
Oct 24, 2024
Director
Uninformative Buy
$20.01M
Voyager Therapeutics
Director
Exelixis
May 20, 2020
Director
Uninformative Sell
1.95M
$26.76M
Agilent
May 31, 2024
Director
Uninformative Sell
500.89K
$4.98M
List of latest transactions for each holding click on a transaction to see George Scangos's performance on stock

George Scangos insider profile FAQ

What is the percentage of profitable transactions made by George Scangos?
The percentage of profitable transactions made by George Scangos is 71%.
    What is the average return per transaction made by George Scangos?
    The average return per transaction made by George Scangos is 11.90%.
      What stocks does George Scangos hold?
      George Scangos holds: BIIB, VIR, VYGR, EXEL, A stocks.
        What was George Scangos’s latest transaction?
        George Scangos latest transaction was an Uninformative Buy of ―.
          What was George Scangos's most profitable transaction?
          George Scangos’s most profitable transaction was an Informative Sell of VIR stock on February 21, 2023. The return on the trade was 62.50%.
            What is George Scangos's role in Biogen?
            George Scangos's role in Biogen is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.